TRISENOX Trademark

Trademark Overview

On Wednesday, April 26, 2000, a trademark application was filed for TRISENOX with the United States Patent and Trademark Office. The USPTO has given the TRISENOX trademark a serial number of 76033973. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 3, 2022. This trademark is owned by Cell Therapeutics, Inc.. The TRISENOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of cancer
trisenox

General Information

Serial Number76033973
Word MarkTRISENOX
Filing DateWednesday, April 26, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 3, 2022
Registration Number2509161
Registration DateTuesday, November 20, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 28, 2001

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 3, 2022
Primary Code005
First Use Anywhere DateTuesday, October 10, 2000
First Use In Commerce DateTuesday, October 10, 2000

Trademark Owner History

Party NameCEPHALON LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWEST CHESTER, PA 19380
Party NameCephalon, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameCell Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Wednesday, December 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 3, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, July 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 14, 2021TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, July 14, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 14, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 20, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, November 3, 2011REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, November 3, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 27, 2011TEAS SECTION 8 & 9 RECEIVED
Thursday, October 27, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 27, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 21, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 21, 2007ASSIGNED TO PARALEGAL
Monday, November 19, 2007TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 16, 2007CASE FILE IN TICRS
Tuesday, November 20, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, August 28, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2001NOTICE OF PUBLICATION
Thursday, April 5, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 5, 2001USE AMENDMENT ACCEPTED
Friday, February 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 3, 2001AMENDMENT TO USE PROCESSING COMPLETE
Friday, February 2, 2001USE AMENDMENT FILED
Thursday, September 28, 2000NON-FINAL ACTION MAILED
Thursday, September 21, 2000ASSIGNED TO EXAMINER

Related Keywords

trisenox cancer treatment used preparations pharmaceutical